11 priorities for building scalable and accessible advanced therapies.
A must-read roadmap for global biotech leaders.
Cell and gene therapies are moving from promise to practice, but scaling the manufacturing from hundreds of doses to treating tens of thousands of patients must not be taken for granted. This industry agenda, based on an international workshop, proposes 11 priority actions for biotech executives on the journey to scale.
- Learn about the industry’s top infrastructure priorities for patient access.
- Understand how you need to work with regulators to accelerate innovation.
- Gain insight into the very latest manufacturing regulations and technology enablers.
- Discover the state of the art in adaptive manufacturing, digitalisation and advanced use cases for AI/ML.
- Get a fresh perspective on the efficiency of different manufacturing models and enablers of high-volume manufacturing.
- Design outperforming partnerships to support automation, customisation and cost reduction.
- Explore the skills needs of the future workforce and policy support to boost manufacturing expansion.
- Learn how to strengthen your hand with investors by showing readiness for scale-up.
- Find out more about industry-wide directions on upstream inputs and tailored policy support.
Put together by technology developers TTP with contributions from Cytiva, Autolus and Limula, this industry agenda cuts through the complexity of process translation and will help you to unlock commercial scale.
Offered Free by: TTP
See All Resources from: TTP
